Shoott to Partner with TechCon SoCal 2026 Biomea Announces Pricing of Initial Public Offering
REDWOOD CITY, Calif., April 15, 2021 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA),…
Akoya Biosciences Announces Pricing of Initial Public Offering
MARLBOROUGH, Mass., April 15, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
ContraFect Invited to Present at the Inaugural Anti-Infectives Drug Development Summit
YONKERS, N.Y., April 15, 2021 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage…
Revive Reschedules Annual and Special Meeting and Provides Dial-In Information
TORONTO, April 15, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free Action Plan
New Zealand Ministry of Health Proposal Calls for Reducing Nicotine Content in Cigarettes to “Minimal…
Golden Leaf to Report Fiscal 2020 and Fourth Quarter 2020 Results on Tuesday April 27th
PORTLAND, Ore., April 15, 2021 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB:…
Tower One Construction Update for the Month of March 2021
VANCOUVER, British Columbia, April 15, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO)…
Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026
NASHVILLE, Tenn., April 15, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health”…
Adamis Pharmaceuticals Announces 2020 Financial Results and Business Update
Phase 2/3 clinical trial for Tempol for the prevention of hospitalizations in patients with COVID-19…
Biogen Grows Presence in China with the Approval of TECFIDERA® (dimethyl fumarate) for the Treatment of Relapsing Multiple Sclerosis
TECFIDERA was approved under the National Medical Products Administration priority review process evaluating therapies with…
Praxis Precision Medicines Adds Development Expertise to Board of Directors with Appointment of Jeffrey Chodakewitz, M.D.
CAMBRIDGE, Mass., April 15, 2021 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a…
Pacific Biosciences of California, Inc. First Quarter 2021 Financial Results Call
MENLO PARK, Calif., April 15, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:…
Avid Bioservices Announces Completion of Redemption of Series E Convertible Preferred Stock
TUSTIN, Calif., April 15, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (the “company”),…
Collegium to Host Conference Call to Discuss First Quarter 2021 Financial Results and Provide Corporate Update
STOUGHTON, Mass., April 15, 2021 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today…
TG Therapeutics to Host Investor & Analyst Event to Preview Results from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis
Webcast to be held tomorrow, April 16, 2021 at 8:30 AM ET NEW YORK, April…
Infant Bacterial Therapeutics receives additional patent protection in China
Infant Bacterial Therapeutics AB (IBT) today announces that the Chinese patent office has issued a…
Nabriva Commences Exclusive Distribution of SIVEXTRO® (tedizolid phosphate) in the U.S.
– SIVEXTRO now available under Nabriva’s National Drug Code – 100% of SIVEXTRO’s net product…
GigaGen Publishes Research on Company’s Recombinant Hyperimmunes in Nature Biotechnology
Article describes GigaGen’s technology and approach for the production of a new class of drug,…
Virbac: very strong growth in revenue in the first quarter of 2021 at +22.6% at comparable exchange rates and scope (+12.3% at constant rates), driven by very solid performance in all areas
KEY FIGURES Revenue1st quarter 2021 €266.5 million Growth at constant exchange rates and…
GBS, Inc. Receives Approval to Commence Validation Clinical Study for Rapid SARS-CoV-2 Diagnostic Test
NEW YORK, April 15, 2021 (GLOBE NEWSWIRE) — GBS, Inc. (NasdaqGS: GBS), a life sciences…